Rani Hagag

Rani Hagag was appointed Chief Health Care & Consumer Business Officer in December, 2022. Prior to joining Stratasys, Hagag served as CEO at OrCam Technologies, a leading AI solutions innovator in the domain of consumers' health and assistive technologies. Previously, Hagag was the President of Lumenis' Medical Aesthetics Group, where he led the B2B solutions, as well as the consumer products businesses. Prior to Lumenis, Hagag was the Co-founder and CEO of Biopolymer Tech, a biochemicals company that developed and commercialized a disruptive technology to transform abundant plant proteins into industrial materials. The company was acquired by the French Government Bank and Groupe Avril to form Evertree, a global, green-industrial business. Earlier, Hagag was with Comverse, a global telecom solutions provider, and held leadership positions of Corporate Strategy and Business Development, VP Products and Marketing, as well as General Management roles. Prior to Comverse, Hagag spent several years as a strategy consultant with Arthur D. Little.

Hagag holds an LL.B. (Honors) from the University of Oxford Brookes and an MBA from the University of London.